全部股東
股東類型
- 上市公司43.46%
- 公眾及其他32.46%
- 機構投資者14.49%
- 對沖基金7.77%
- 個人與內幕人士1.82%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Lin BioScience, Inc. | 43.46% | 1,709.53 萬 | 0.00% | +0 | 28/02/2026 |
Darwin Global Management Limited | 7.77% | 305.74 萬 | 0.08% | +2.97 萬 | 31/03/2026 |
Paradigm Biocapital Advisors LP | 2.83% | 111.48 萬 | -- | +111.48 萬 | 31/03/2026 |
RTW Investments, LP | 1.82% | 71.53 萬 | 0.00% | +0 | 31/03/2026 |
Millennium Management LLC | 1.45% | 57.01 萬 | 0.03% | +1.12 萬 | 31/03/2026 |
Holocene Advisors, LP | 1.26% | 49.45 萬 | 1.04% | +41.04 萬 | 31/03/2026 |
Eventide Asset Management, LLC | 0.91% | 35.77 萬 | 0.06% | -2.54 萬 | 31/03/2026 |
Yu-Hsin LinChairman of the Board of Directors & CEO | 0.90% | 35.39 萬 | <0.01% | +800.00 | 21/04/2026 |
Deerfield Management Company, L.P. | 0.77% | 30.40 萬 | 0.18% | +7.02 萬 | 31/03/2026 |
Hao-Yuan ChuangCFO & Director | 0.76% | 29.91 萬 | <0.01% | +3,800.00 | 21/04/2026 |
T. Rowe Price Group, Inc. | 0.72% | 28.18 萬 | -- | +28.18 萬 | 31/03/2026 |
UBS Asset Management AG | 0.57% | 22.50 萬 | 1.38% | -54.34 萬 | 30/06/2026 |
Affinity Asset Advisors, LLC | 0.42% | 16.50 萬 | 0.25% | +10.00 萬 | 30/06/2026 |
Perceptive Advisors LLC | 0.39% | 15.20 萬 | 0.67% | -26.23 萬 | 31/03/2026 |
Patient Square Capital, LP | 0.28% | 11.00 萬 | 0.02% | -6,684.00 | 30/06/2026 |
Duquesne Family Office LLC | 0.27% | 10.61 萬 | -- | +10.61 萬 | 31/03/2026 |
The Goldman Sachs Group, Inc. | 0.27% | 10.55 萬 | 0.00% | +0 | 30/06/2026 |
MPM BioImpact LLC | 0.22% | 8.80 萬 | <0.01% | +285.00 | 31/03/2026 |
Fubon Asset Management Co., Ltd. | 0.20% | 7.99 萬 | <0.01% | -159.00 | 31/03/2026 |
Uni-President Assets Management Corp. | 0.17% | 6.58 萬 | 0.05% | +2.08 萬 | 31/03/2026 |